Clinical trials
Full profile accessFollow clinical development from study design and recruitment through results.
- Trial phase
- Status
- Readouts
Drug intelligence / Profile preview
mepyramine + sodium benzoate
- Development stage
- Unknown
- Lead developer
- Laboratoires Elerté
- Modality
- Small Molecules
- Administration
- Oral
01
Overview
FluiSédal is a combination pharmaceutical product developed by Laboratoires Élerté for the treatment of respiratory tract conditions, specifically non-productive coughs. The formulation consists of mepyramine maleate, a first-generation H1-antihistamine, and sodium benzoate. Mepyramine acts as an H1-receptor antagonist, providing antitussive and sedative effects that are particularly useful for nocturnal coughs. Sodium benzoate is traditionally included for its mild bronchial fluidifying properties, intended to assist in the management of respiratory secretions. This product is currently marketed as FluiSédal sans prométhazine to distinguish it from earlier versions that included promethazine, which has a more significant side-effect profile. It is primarily used in the symptomatic relief of dry, irritating coughs in both adults and children.
- Brand names
- FluiSédalFluiSédal sans prométhazine
- Other names
- FluiSédal sans prométhazinemepyramine maleate + sodium benzoate
02
Targets
HRH1 (Histamine H1 Receptor)
Beyond the preview
Go deeper on mepyramine + sodium benzoate.
Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.
Indications & development
Full profile accessExplore development by indication, patient population, and geography.
- Indications
- Development status
- Countries
Licensing & deals
Full profile accessTrace asset ownership, licensing agreements, and commercial partnerships.
- Partners
- Deal terms
- Milestones
Patents & exclusivity
Full profile accessExplore the patent landscape and regulatory exclusivity around an asset.
- Patents
- Expiration dates
- Exclusivity
Competitive landscape
Full profile accessCompare development programs by target, modality, and indication.
- Competing assets
- Targets
- Development stage
Research & analysis
Full profile accessConnect source evidence and development news to your research questions.
- Publications
- News
- Analysis
Bring the full picture into focus.
See how Gosset can support your research on mepyramine + sodium benzoate.